| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8630258 | Diabetes Research and Clinical Practice | 2018 | 20 Pages |
Abstract
DPP-4 inhibitors are not associated with an increased risk of fragility fractures compared with SUs or insulin; however, are associated with a lower risk versus thiazolidinediones.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
John-Michael Gamble, Jennifer R. Donnan, Eugene Chibrikov, Laurie K. Twells, William K. Midodzi, Sumit R. Majumdar,